283 related articles for article (PubMed ID: 15337824)
21. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium.
Pellati F; Benvenuti S
J Chromatogr A; 2007 Aug; 1161(1-2):71-88. PubMed ID: 17582424
[TBL] [Abstract][Full Text] [Related]
22. Review of Published Bitter Orange Extract and
Stohs SJ; Ray SD
J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
[No Abstract] [Full Text] [Related]
23. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
Perova IB; Eller KI; Musatov AV; Tymolskaya EV
Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
[TBL] [Abstract][Full Text] [Related]
24. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
[TBL] [Abstract][Full Text] [Related]
25. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.
Bouchard NC; Howland MA; Greller HA; Hoffman RS; Nelson LS
Mayo Clin Proc; 2005 Apr; 80(4):541-5. PubMed ID: 15819293
[TBL] [Abstract][Full Text] [Related]
26. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice.
Arbo MD; Schmitt GC; Limberger MF; Charão MF; Moro AM; Ribeiro GL; Dallegrave E; Garcia SC; Leal MB; Limberger RP
Regul Toxicol Pharmacol; 2009 Jul; 54(2):114-7. PubMed ID: 19275924
[TBL] [Abstract][Full Text] [Related]
27. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
[TBL] [Abstract][Full Text] [Related]
28. Developmental toxicity of Citrus aurantium in rats.
Hansen DK; Juliar BE; White GE; Pellicore LS
Birth Defects Res B Dev Reprod Toxicol; 2011 Jun; 92(3):216-23. PubMed ID: 21594979
[TBL] [Abstract][Full Text] [Related]
29. Analysis of bitter orange dietary supplements for natural and synthetic phenethylamines by LC-MS/MS.
Pawar RS; Sagi S; Leontyev D
Drug Test Anal; 2020 Sep; 12(9):1241-1251. PubMed ID: 32497396
[TBL] [Abstract][Full Text] [Related]
30. Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity.
Verpeut JL; Walters AL; Bello NT
Nutr Res; 2013 Jun; 33(6):503-12. PubMed ID: 23746567
[TBL] [Abstract][Full Text] [Related]
31. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
[TBL] [Abstract][Full Text] [Related]
32. A rapid and simple procedure for the determination of synephrine in dietary supplements by gas chromatography-mass spectrometry.
Marchei E; Pichini S; Pacifici R; Pellegrini M; Zuccaro P
J Pharm Biomed Anal; 2006 Jun; 41(4):1468-72. PubMed ID: 16698212
[TBL] [Abstract][Full Text] [Related]
33. Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC.
Pellati F; Benvenuti S; Melegari M; Firenzuoli F
J Pharm Biomed Anal; 2002 Aug; 29(6):1113-9. PubMed ID: 12110397
[TBL] [Abstract][Full Text] [Related]
34. Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection.
Slezak T; Francis PS; Anastos N; Barnett NW
Anal Chim Acta; 2007 Jun; 593(1):98-102. PubMed ID: 17531829
[TBL] [Abstract][Full Text] [Related]
35. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats.
Arbo MD; Franco MT; Larentis ER; Garcia SC; Sebben VC; Leal MB; Dallegrave E; Limberger RP
Arch Toxicol; 2009 Jan; 83(1):95-9. PubMed ID: 18651134
[TBL] [Abstract][Full Text] [Related]
36. Absence of furanocoumarins in Advantra Z® (Citrus aurantium, bitter orange) extracts.
Stohs SJ; Miller H; Romano F
J Diet Suppl; 2014 Sep; 11(3):288-93. PubMed ID: 25026202
[TBL] [Abstract][Full Text] [Related]
37. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
Kaats GR; Miller H; Preuss HG; Stohs SJ
Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
[TBL] [Abstract][Full Text] [Related]
38. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
Nykamp DL; Fackih MN; Compton AL
Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
[TBL] [Abstract][Full Text] [Related]
39. The Safety and Efficacy of
Koncz D; Tóth B; Bahar MA; Roza O; Csupor D
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235672
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular toxicity of Citrus aurantium in exercised rats.
Hansen DK; George NI; White GE; Abdel-Rahman A; Pellicore LS; Fabricant D
Cardiovasc Toxicol; 2013 Sep; 13(3):208-19. PubMed ID: 23397375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
